|
1
|
Keum N and Giovannucci E: Global burden of
colorectal cancer: Emerging trends, risk factors and prevention
strategies. Nat Rev Gastroenterol Hepatol. 16:713–732.
2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Xia C, Dong X, Li H, Cao M, Sun D, He S,
Yang F, Yan X, Zhang S, Li N and Chen W: Cancer statistics in China
and United States, 2022: Profiles, trends, and determinants. Chin
Med J (Engl). 135:584–590. 2022.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Dekker E, Tanis PJ, Vleugels JLA, Kasi PM
and Wallace MB: Colorectal cancer. Lancet. 394:1467–1480.
2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Cayrol C and Girard JP: Interleukin-33
(IL-33): A nuclear cytokine from the IL-1 family. Immunol Rev.
281:154–168. 2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Lee S, Chang J, Renvoisé B, Tipirneni A,
Yang S and Blackstone C: MITD1 is recruited to midbodies by
ESCRT-III and participates in cytokinesis. Mol Biol Cell.
23:4347–4361. 2012.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Shen H, Wang Z, Ren S, Wang W, Duan L, Zhu
D, Zhang C and Duan Y: Prognostic biomarker MITD1 and its
correlation with immune infiltrates in hepatocellular carcinoma
(HCC). Int Immunopharmacol. 81(106222)2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Duan C: LncRNA SLC16A1-AS1 contributes to
the progression of hepatocellular carcinoma cells by modulating
miR-411/MITD1 axis. J Clin Lab Anal. 36(e24344)2022.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Zhang Y, Li Y, Qiu Q, Chen Z, Du Y and Liu
X: MITD1 deficiency suppresses clear cell renal cell carcinoma
growth and migration by inducing ferroptosis through the
TAZ/SLC7A11 pathway. Oxid Med Cell Longev.
2022(7560569)2022.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Li JH, Liu S, Zhou H, Qu LH and Yang JH:
starBase v2.0: Decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA
interaction networks from large-scale CLIP-Seq data. Nucleic Acids
Res. 42:D92–D97. 2014.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Li C, Tang Z, Zhang W, Ye Z and Liu F:
GEPIA2021: Integrating multiple deconvolution-based analysis into
GEPIA. Nucleic Acids Res. 49:W242–W246. 2021.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Health Commission Of The People's Republic
Of China N. National guidelines for diagnosis and treatment of
colorectal cancer 2020 in China (English version). Chin J Cancer
Res. 32:415–445. 2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Chen C and Sheng Y: Prognostic impact of
MITD1 and associates with immune infiltration in kidney renal clear
cell carcinoma. Technol Cancer Res Treat.
20(15330338211036233)2021.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Chen Y, Xu T, Xie F, Wang L, Liang Z, Li
D, Liang Y, Zhao K, Qi X, Yang X and Jiao W: Evaluating the
biological functions of the prognostic genes identified by the
pathology atlas in bladder cancer. Oncol Rep. 45:191–201.
2021.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Kong N, Chen X, Feng J, Duan T, Liu S, Sun
X, Chen P, Pan T, Yan L, Jin T, et al: Baicalin induces ferroptosis
in bladder cancer cells by downregulating FTH1. Acta Pharm Sin B.
11:4045–4054. 2021.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Liang Y, Zhang L, Peng C, Zhang S, Chen S,
Qian X, Luo W, Dan Q, Ren Y, Li Y and Zhao B: Tumor
microenvironments self-activated nanoscale metal-organic frameworks
for ferroptosis based cancer chemodynamic/photothermal/chemo
therapy. Acta Pharm Sin B. 11:3231–3243. 2021.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Wei R, Zhao Y, Wang J, Yang X, Li S, Wang
Y, Yang X, Fei J, Hao X, Zhao Y, et al: Tagitinin C induces
ferroptosis through PERK-Nrf2-HO-1 signaling pathway in colorectal
cancer cells. Int J Biol Sci. 17:2703–2717. 2021.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Zheng X, Wang Q, Zhou Y, Zhang D, Geng Y,
Hu W, Wu C, Shi Y and Jiang J: N-acetyltransferase 10 promotes
colon cancer progression by inhibiting ferroptosis through
N4-acetylation and stabilization of ferroptosis suppressor protein
1 (FSP1) mRNA. Cancer Commun (Lond). 42:1347–1366. 2022.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Chen L, Luo C, Shen L, Liu Y, Wang Q,
Zhang C, Guo R, Zhang Y, Xie Z, Wei N, et al: SRSF1 prevents DNA
damage and promotes tumorigenesis through regulation of DBF4B
Pre-mRNA splicing. Cell Rep. 21:3406–3413. 2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Li H, Guo S, Zhang M, Li L, Wang F and
Song B: Long non-coding RNA AGAP2-AS1 accelerates cell
proliferation, migration, invasion and the EMT process in
colorectal cancer via regulating the miR-4,668-3p/SRSF1 axis. J
Gene Med. 22(e3250)2020.PubMed/NCBI View
Article : Google Scholar
|
|
21
|
Zhao A and Liu Y: Propofol suppresses
colorectal cancer development by the circ-PABPN1/miR-638/SRSF1
axis. Anal Biochem. 631(114354)2021.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Luo C, Nie C, Zeng Y, Qian K, Li X and
Wang X: LINC01564 promotes the TMZ resistance of glioma cells by
upregulating NFE2L2 expression to inhibit ferroptosis. Mol
Neurobiol. 59:3829–3844. 2022.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Miyajima C, Hayakawa Y, Inoue Y, Nagasaka
M and Hayashi H: HMG-CoA reductase inhibitor statins activate the
transcriptional activity of p53 by regulating the expression of
TAZ. Pharmaceuticals (Basel). 15(1015)2022.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Zeng C, Lin J, Zhang K, Ou H, Shen K, Liu
Q, Wei Z, Dong X, Zeng X, Zeng L, et al: SHARPIN promotes cell
proliferation of cholangiocarcinoma and inhibits ferroptosis via
p53/SLC7A11/GPX4 signaling. Cancer Sci. 113:3766–3775.
2022.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Wu ZH, Liu CC, Zhou YQ, Hu LN and Guo WJ:
OnclncRNA-626 promotes malignancy of gastric cancer via inactivated
the p53 pathway through interacting with SRSF1. Am J Cancer Res.
9:2249–2263. 2019.PubMed/NCBI
|
